GLAXF - GlaxoSmithKline plc

Other OTC - Other OTC Delayed price. Currency in USD
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Cash flows from operating activities
Net income
4,561,000
3,623,000
1,532,000
912,000
8,422,000
Depreciation & amortisation
3,159,000
1,856,000
1,922,000
1,774,000
1,862,000
Deferred income taxes
-
-
-
-
-
Stock-based compensation
-
360,000
333,000
319,000
368,000
Change in working capital
-102,000
2,235,000
823,000
1,727,000
1,675,000
Accounts receivable
-
-
-
-188,000
98,000
Inventory
-
51,000
-461,000
70,000
-111,000
Accounts payable
-
-
-
96,000
40,000
Other working capital
6,653,000
6,625,000
4,716,000
4,145,000
668,000
Other non-cash items
1,263,000
961,000
941,000
2,563,000
653,000
Net cash provided by operating activities
8,686,000
8,421,000
6,918,000
6,497,000
2,569,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,033,000
-1,796,000
-2,202,000
-2,352,000
-1,901,000
Acquisitions, net
-3,674,000
-163,000
-106,000
-84,000
-3,557,000
Purchases of investments
-
-309,000
-76,000
-96,000
-84,000
Sales/maturities of investments
116,000
151,000
64,000
683,000
357,000
Other investing activities
-
-153,000
-91,000
-73,000
-2,000
Net cash used for investing activities
-5,397,000
-1,553,000
-1,443,000
-1,269,000
6,037,000
Cash flows from financing activities
Debt repayment
-4,283,000
-2,067,000
-3,200,000
-919,000
-2,412,000
Common stock issued
84,000
74,000
-9,000
15,000
-26,000
Common stock repurchased
-
-
-65,000
0
0
Dividends paid
-3,946,000
-3,927,000
-3,906,000
-4,850,000
-3,874,000
Other financing activities
-68,000
-9,324,000
85,000
-421,000
233,000
Net cash used provided by (used for) financing activities
-
-
-
-
-
Net change in cash
962,000
479,000
-905,000
-1,164,000
1,503,000
Cash at beginning of period
3,587,000
3,600,000
4,605,000
5,486,000
4,028,000
Cash at end of period
4,549,000
4,087,000
3,600,000
4,605,000
5,486,000
Free cash flow
Operating cash flow
8,686,000
8,421,000
6,918,000
6,497,000
2,569,000
Capital expenditure
-2,033,000
-1,796,000
-2,202,000
-2,352,000
-1,901,000
Free cash flow
6,653,000
6,625,000
4,716,000
4,145,000
668,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more